Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna is in a strong financial position with $516.5M in cash, cash equivalents and marketable securities, enough to fund operations until 2029. The company's pipeline is focused on three therapeutic areas and its proprietary Native Complex Platform has the potential to unlock the full potential of GPCR therapies. Septerna's lead candidate, SEP-479, has shown a 3-4 day human half-life and Phase 1 data is expected in 2027, which could be a major de-risking event. The company's financial results have been better than expected, and with a strong cash runway and potential positive data in the near future, the analyst has a positive outlook on the company's stock.

Bears say

Septerna is facing significant risks to its stock price target achievement due to delays and setbacks in clinical trials, partnership risks, and potential approval failures for its lead candidates. Additionally, the estimated valuation of $60 per share is based on a conservative assessment of the company's pipeline, and there is a possibility for long-term dilution risk. The company's current phase 1 trial of SEP-479, its lead PTH1R candidate, has shown positive PK data but may not report conclusive results until 2027, with a potential launch in 2031. The bull case for the company's stock price is $70, assuming a 50% probability of success for SEP-479 and potential revenue of $2.3B in 2040.

Septerna Inc (SEPN) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 8 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $49, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $49, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.